[China Wind Systems, Inc. Reports Second Quarter 2010 Results -- Second quarter 2010 revenues increased 39.7% to $19.0 million -- Net income increased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, Inc. (Nasdaq: Second Quarter 2010 Highlights and Recent Events -- Net revenue increased 39.7%]
[China Wind Systems, Inc. Reports Second Quarter 2010 Results -- Second quarter 2010 revenues increased 39.7% to $19.0 million -- Net income increased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, Inc. (Nasdaq: Second Quarter 2010 Highlights and Recent Events -- Net revenue increased 39.7%]
[China Wind Systems, Reports Second Quarter 2010 Results -- Second quarter 2010 revenuesreased 39.7% to $19.0 million -- Netomereased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, (Nasdaq: Second Quarter 2010 Highlights and Recent Events]
[China Wind Systems, Reports Second Quarter 2010 Results -- Second quarter 2010 revenuesreased 39.7% to $19.0 million -- Netomereased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, (Nasdaq: Second Quarter 2010 Highlights and Recent Events]
[China Wind Systems, Reports Second Quarter 2010 Results -- Second quarter 2010 revenuesreased 39.7% to $19.0 million -- Netomereased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, (Nasdaq: Second Quarter 2010 Highlights and Recent Events]
[Skystar Bio-Pharmaceutical Reports 33% Growth in Revenue From Continuing Operations in Second Quarter Fiscal Year 2010 Gross Margin Remains of 53%; $0.33 Diluted Earnings Per Share; Company reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million XI’AN, CHINA – August 17, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Second Quarter 2010 Highlights · Revenue increases]
[China Wind Systems, Reports Second Quarter 2010 Results -- Second quarter 2010 revenuesreased 39.7% to $19.0 million -- Netomereased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, (Nasdaq: Second Quarter 2010 Highlights and Recent Events]
[99.1 Press Release issued by the Company on August 16, 2010: eLong Reports Second Quarter 2010 Unaudited Financial Results DATED: August 17, 2010 ELONG, INC Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China August 16, 2010 eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited]
[99.1 Press Release issued by the Company on August 16, 2010: eLong Reports Second Quarter 2010 Unaudited Financial Results DATED: August 17, 2010 ELONG, INC Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China August 16, 2010 eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited]
[BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenue increased 46.4% to $19.4 million - Q2 2010 Non-GAAP adjusted net income increased 50.9% to $5.8 million with adjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and net income]
